Austin, Texas — According to state and local economic development sources Babson Diagnostics plans to invest $600,000.00 to build out 20,000 square feet of new space in Austin. The company plans to occupy the new space at 1321 Rutherford, Building B, Ste. 200 in Austin, on or about September 1, 2022. According to the company website Babson Diagnostics is bringing medically-accurate blood testing to the pharmacy, and empowering people to take charge of their health by reimagining the entire blood testing process from ordering, collection, handling, analyzing, and reporting of results, making it less invasive and more convenient, accessible, and patient-centered.

To learn more about Babson Diagnostics, visit http://www.babsondx.com/

Company Contact:
David Stein, Chief Executive Officer
https://www.linkedin.com/in/david-stein-ceo/
512-562-2473

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved